HLB PEP Co., Ltd.

HLB PEP Co., Ltd. is a South Korean biotechnology company specializing in the research, development, and manufacturing of peptide-based biomaterials and pharmaceutical ingredients. It is recognized as the first bio-venture company in the Gwangju and Jeonnam provinces and operates Korea's first GMP-certified facility dedicated to the production of peptide active pharmaceutical ingredients (APIs). The company focuses on both custom peptide synthesis for research and commercial purposes and the development of its own proprietary drug pipeline, particularly in oncology and rare diseases. HLB PEP leverages advanced peptide synthesis technologies, including Solid-Phase Peptide Synthesis (SPPS) and Solution Phase Peptide Synthesis (SPS), to support its internal drug development and provide contract manufacturing services to global pharmaceutical partners.